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po the Editor: Apical ballooning syndrome (ABS), also referred to as
ako-Tsubo or stress-induced cardiomyopathy, is a unique reversible
ardiovascular disease that mimics an acute myocardial infarction (1).
atecholamine-induced myocardial stunning has been postulated as a
entral mechanism, but the precise pathophysiology remains un-
nown (2,3). We hypothesized that the susceptibility to the cardio-
yopathy may, in part, be related to pre-morbid chronic psychiatric
nd cardiovascular diseases, and our aim was to assess the burden of
hese diseases among patients who had suffered ABS.
A retrospective case-control study was conducted among patients
ho were prospectively diagnosed with ABS according to the Mayo
linic diagnostic criteria (2). The study was restricted to Olmsted
ounty, Minnesota, residents because the Mayo Clinic is the only
ertiary heath care provider for the region; hence, their medical records
ould provide a complete past medical history for major acute and
hronic diseases. Twenty-five female patients met inclusion criteria.
wenty-five Olmsted County residents with a prior history of an
nterior ST-segment elevation myocardial infarction (STEMI) served
s one control group. A second control group of 50 Olmsted County
esidents was drawn from the general population of patients seen at
he Mayo Clinic in Rochester. Both control groups were matched for
ge, date of birth, and sex. The STEMI group was also matched for
he index event date, and the general control subjects were seen at the
ayo Clinic within 5 years of the ABS patients’ event date. The study
as approved by the Mayo Clinic Institutional Review Board, and all
ubjects consented to the use of their medical records for research.We
eviewed the complete medical records of each patient and control
ubject and documented details of the past psychiatric and cardiovas-
ular history preceding the episode of ABS. The diagnosis of anxiety
ncluded generalized anxiety disorder, panic disorder, post-traumatic
tress disorder, obsessive-compulsive disorder, and social phobia.
ubstance abuse included alcohol and illicit drug use. Continuous
ariables are summarized as mean  SD if they have roughly
ymmetric distributions; otherwise median (interquartile range) is the
ummary format. Categorical data are presented as frequency (group
ercentage); percentages are relative to those with data available.
ifferences between matched cases and control subjects were tested
sing conditional logistic regression.
The mean age of the ABS patients was 70.6  12.2 years. There
ere no differences in the predominant presenting symptoms of chest
ain and dyspnea or the occurrence of congestive heart failure and
rrhythmias between the ABS patients and STEMI control subjects.
oronary atherosclerosis was present in 92% of ABS patients,
lthough only 1 patient had a stenosis 70% in a major epicardial
rtery. The frequency of chronic anxiety disorders was significantly
reater in patients with ABS compared with both control groups ATable 1). Compared with the general population control subjects,
BS patients were more likely to have been divorced (20% vs. 2%;
 0.012) and to be living alone (52% vs. 24%, p 0.024). The total
umber of conventional cardiovascular risk factors in patients with
BS was similar to that in STEMI patients, but higher when
ompared with the general population (Table 1).
The major findings of this study are that patients with ABS have:
) a high prevalence of a chronic anxiety disorder that antecedes the
nset of the cardiomyopathy; and 2) a high prevalence of comorbid
ardiovascular risk factors with frequency similar to that seen in
atients with STEMI. The present study is the first to report an
ssociation between chronic psychiatric illness and ABS; 56% of
atients with ABS had been diagnosed with a chronic anxiety disorder
y either a primary physician or a psychiatrist before the hospitaliza-
ion for ABS. A diagnosis of either anxiety or depression was
ocumented in more than two-thirds of patients with ABS. The
requency was significantly higher than that in the STEMI and
eneral population control subjects. This observation, together with
he higher frequency of a family history of anxiety or depression, and
ocial isolation, suggests that psychosocial factors may be a pre-
isposing risk factor in the pathophysiology of ABS. This is plausible
iven the fact that acute emotional stress is a well-recognized trigger
or ABS (1,2). Thus, we speculate that chronic psychological stress may
e a risk factor, whereas acute anxiety may ultimately trigger the
yndrome. Proposed stress-related mechanisms that may promote
therogenesis include activation of the hypothalamic–pituitary–adrenal
nd sympathetic nervous systems, serotonergic dysfunction, secretion of
roinflammatory cytokines, and platelet activation (4). The same mech-
nisms could also precipitate myocardial dysfunction that occurs in ABS.
Patients with ABS had a high prevalence of conventional cardio-
ascular risk factors. The majority had at least 2 of the following:
ypertension, hyperlipidemia, diabetes mellitus, history of smoking,
r a family history of cardiovascular disease. This may not seem
nusual for an elderly cohort; however, it is noteworthy that the
umulative burden of cardiovascular risk was significantly greater in
atients with ABS than that of the general population, and similar to
hat of the STEMI control subjects. The finding is consistent with the
act that 92% of patients with ABS had angiographic evidence of
oronary atherosclerosis, although only 1 had an obstructive lesion.
ecause nonobstructive atherosclerosis and its risk factors seem to be
biquitous in ABS, we speculate that endothelial dysfunction may
lay a role in the pathophysiology.
Further studies need to confirm our findings in larger cohorts, and
f the associations are consistently present, detailed study of the
sychosocial attributes, personality traits, and chronic life stress in
BS patients would be indicated. If chronic psychiatric conditions
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February 16, 2010:700–3nd cardiovascular risk factors were confirmed to play a role in the
athophysiology, it would be important to clearly identify and treat
hem with a view to preventing recurrence (1,2,5).
atthew R. Summers, BS
yan J. Lennon, MS
Abhiram Prasad, MD
Mayo Clinic
00 First Street SW
ochester, Minnesota 55905
-mail: prasad.abhiram@mayo.edu
Pre-Morbid Psychiatric and Cardiovascular HistoryTable 1 Pre-Morbid Psychiatric and Cardiovascula
Variable
ABS
(n  2
Anxiety 14 (56
Depression 12 (48
Anxiety or depression 17 (68
Substance abuse 5 (20
History of emotional or physical abuse 4 (16
Total psychiatric diagnoses 1.40 1
Family history of anxiety or depression 11 (44
Hypertension 19 (76
Hyperlipidemia 13 (52
Diabetes mellitus 4 (16
Former or current smoking history 18 (72
Total cardiovascular risk factors 2.68 1
Values are n (%) or mean  SD. *p  0.01 for comparison with patie
ABS  apical ballooning syndrome; STEMI  ST-segment elevationdoi:10.1016/j.jacc.2009.10.031
erformed a study of 54 patients (mean age 68 years, 79% men)
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STEMI
(n  25)
General Control Subjects
(n  50)
3 (12%)* 9 (18%)*
7 (28%) 11 (22%)
9 (36%)† 15 (30%)*
2 (8%) 3 (6%)
0 (0%)† 1 (2%)†
0.52 0.71* 0.54 0.89*
1 (4%)* 7 (14%)*
19 (76%) 30 (60%)
18 (72%) 32 (64%)
5 (20%) 7 (14%)
12 (48%) 17 (34%)*
2.52 1.19 1.88 1.27†
ABS. †p  0.05.
rdial infarction.208–25.Letters to the Editorurther Barriers to Conversations
bout Deactivation of Implantable
ardioverter-Defibrillators
e read the recent report by Goldstein et al. (1) with interest.
heir study polled 147 doctors who looked after patients with
mplantable cardioverter-defibrillators (ICDs) regarding perceived
arriers to end-of-life discussions with these patients. Although it
llustrates that doctors have a high degree of confidence in their
kills in end-of-life discussions with ICD patients, we believe that
octors may in general be substantially overestimating patients’
evel of understanding of the device.
In the report by Goldstein et al. (1), for instance, 93% of the
ardiologists believed that their patients understood why they had
n ICD. Most clinicians also believed that patients knew the ICD
ould be deactivated. Our own data, which is from the patient
erspective, suggests a far poorer understanding of their ICDs. Weith an ICD in situ for chronic heart failure. None had a
ombined device for biventricular pacing.
Patients had a generally disappointing understanding of the
evice. Only 38% of patients were aware that the device could be
eactivated without being explanted. Only 65% of patients felt
hey understood the device as well as they would like to in order to
ake decisions. In fact, although 85% of patients understood that
he device administered a shock, only 65% of patients understood
hat function of the device was solely to prevent sudden cardiac
eath rather than to improve symptoms.
Toward the end of the life of a patient with heart failure, the
evice can deliver painful and frightening shocks. Timely consid-
ration and discussion of deactivation may allow this period to be
ore peaceful and natural.
However, if the patient does not understand how the device
orks, and the doctor does not realize that the patient does not
nderstand, how can such a discussion be effective?
Claire Raphael, MA, BSc
rapa Kanagaratnam, PhDr Hist
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